Venetoclax salvage therapy in relapsed/refractory multiple myeloma

被引：3
|
作者：
Steinhardt, Maximilian J. [1 ]
Truger, Marietta [2 ]
Bittrich, Max [1 ]
Zhou, Xiang [1 ]
Noderer, Julia [1 ]
Riedhammer, Christine [1 ]
Xiao, Xianghui [1 ]
Gawlas, Sophia [1 ]
Weis, Philipp [1 ]
Eisele, Florian [1 ]
Haferlach, Claudia [2 ]
Mersi, Julia [1 ]
Waldschmidt, Johannes [1 ]
Einsele, Hermann [1 ]
Rasche, Leo [1 ,3 ]
Kortuem, K. Martin [1 ]
机构：
[1] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[2] MLL Munich Leukemia Lab, Munich, Germany
[3] Univ Klinikum Wurzburg, Mildred Scheel Early Career Ctr, Wurzburg, Germany
来源：
HAEMATOLOGICA | 2024年 / 109卷 / 03期
关键词：
DEXAMETHASONE; COMBINATION;
D O I：
10.3324/haematol.2023.283472
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：979 / 981
页数：3
相关论文
共 50 条
  • [1] Venetoclax salvage therapy in relapsed/refractory multiple myeloma
    Steinhardt, M.
    Truger, M.
    Bittrich, M.
    Zhou, X.
    Noderer, J.
    Riedhammer, C.
    Xiao, X.
    Gawlas, S.
    Philipp, W.
    Eisele, F.
    Haferlach, C.
    Mersi, J.
    Waldschmidt, J.
    Einsele, H.
    Rasche, L.
    Kortuem, K. M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 58 - 58
  • [2] Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma
    Kumar, S.
    Kaufman, J. L.
    Mikhael, J.
    Gasparetto, C.
    Vij, R.
    Pegourie, B.
    Benboubker, L.
    Facon, T.
    Moreau, P.
    Amiot, M.
    Alzate, S.
    Dunbar, M.
    Xu, T.
    Agarwal, S.
    Leverson, J.
    Ross, J.
    Maciag, P.
    Verdugo, M.
    Touzeau, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 100 - 101
  • [3] VENETOCLAX AS TARGETED THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Kumar, S.
    Kaufman, J. L.
    Mikhael, J.
    Gasparetto, C.
    Vij, R.
    Pegourie, B.
    Benboubker, L.
    Facon, T.
    Moreau, P.
    Amiot, M.
    Alzate, S.
    Dunbar, M.
    Xu, T.
    Agarwal, S.
    Leverson, J.
    Ross, J.
    Maciag, P.
    Verdugo, M.
    Touzeau, C.
    HAEMATOLOGICA, 2017, 102 : 268 - 269
  • [4] Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma
    Kumar, Shaji
    Kaufman, Jonathan L.
    Mikhael, Joseph
    Gasparetto, Cristina
    Vij, Ravi
    Pegourie, Brigitte
    Benboubker, Lofti
    Facon, Thierry
    Moreau, Philippe
    Amiot, Martine
    Alzate, Stefanie
    Dunbar, Martin
    Xu, Tu
    Agarwal, Suresh
    Leverson, Joel
    Ross, Jeremy
    Maciag, Paulo
    Verdugo, Maria
    Touzeau, Cyrille
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E27 - E27
  • [5] Safety and Efficacy of Venetoclax Salvage Therapy in Relapsed/Refractory Multiple Myeloma with and without t(11;14)
    Steinhardt, Maximilian J.
    Bittrich, Max
    Zhou, Xiang
    Noderer, Julia
    Riedhammer, Christine
    Xiao, Xianghui
    Gawlas, Sophia
    Weis, Philipp
    Eisele, Florian
    Munawar, Umair
    Han, Seungbin
    Mersi, Julia
    Waldschmidt, Johannes M.
    Einsele, Hermann
    Rasche, Leo
    Kortuem, K. Martin
    BLOOD, 2023, 142
  • [6] Role of Venetoclax in the Treatment of Relapsed and Refractory Multiple Myeloma
    Ehsan, Hamid
    Wahab, Ahsan
    Shah, Zunairah
    Sana, Muhammad Khawar
    Masood, Adeel
    Rafae, Abdul
    Hashmi, Hamza
    JOURNAL OF HEMATOLOGY, 2021, 10 (03) : 89 - 97
  • [7] Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma
    Boccon-Gibod, Clementine
    Talbot, Alexis
    Le Bras, Fabien
    Frenzel, Laurent
    Royer, Bruno
    Harel, Stephanie
    Lombion, Naelle
    Belhadj, Karim
    Cuccuini, Wendy
    Arnulf, Bertrand
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (03) : E73 - E76
  • [8] Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma
    Tosi, P
    Zamagni, E
    Cellini, C
    Ronconi, S
    Patriarca, F
    Ballerini, F
    Musto, P
    Di Raimondo, F
    Ledda, A
    Lauria, F
    Masini, L
    Gobbi, M
    Vacca, A
    Ria, R
    Cangini, D
    Tura, S
    Baccarani, M
    Cavo, M
    HAEMATOLOGICA, 2002, 87 (04) : 408 - 414
  • [9] Therapy of relapsed and relapsed refractory multiple myeloma
    Driessen, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 113 - 113
  • [10] Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
    Kumar, Shaji
    Kaufman, Jonathan L.
    Gasparetto, Cristina
    Mikhael, Joseph
    Vij, Ravi
    Pegourie, Brigitte
    Benboubker, Lofti
    Facon, Thierry
    Amiot, Martine
    Moreau, Philippe
    Punnoose, Elizabeth A.
    Alzate, Stefanie
    Dunbar, Martin
    Xu, Tu
    Agarwal, Suresh K.
    Enschede, Sari Heitner
    Leverson, Joel D.
    Ross, Jeremy A.
    Maciag, Paulo C.
    Verdugo, Maria
    Touzeau, Cyrille
    BLOOD, 2017, 130 (22) : 2401 - 2409
12345